{"nct_id":"NCT03668613","title":"Study to Assess the Long-term Safety, Tolerability, Efficacy of Secukinumab in Pediatric Patients of Age 6 to <18 Years, With Moderate to Severe Plaque Psoriasis","status":"COMPLETED","status_verified_date":"2025-05","start_date":"2018-08-29","start_date_type":"ACTUAL","primary_completion_date":"2019-09-19","primary_completion_date_type":"ACTUAL","completion_date":"2023-09-12","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["NVS"]}